This presumably resulted in superior survival of not only Luminal A but also Luminal B (HR 2.39) BC subtype compared to lower OS probability of patients with HER2-enriched (HR 6.09) and Basal-like subtype (HR 5.47) [44, 53]. The gene discussed is ERBB2; the disease is breast cancer.